Promore Pharma: Meeting with the FDA regarding PXL01
Research Note
2018-10-23
17:52
Promore announced at market close that the company has completed a meeting with the FDA regarding the development of PXL01 in the US.
MS
Mathias Spinnars
Disclosures and disclaimers